Charles Forsyth

Charles Forsyth is a seasoned finance professional with extensive experience in financial planning and analysis within the biotechnology and healthcare sectors. Currently serving as Senior Director of FP&A & Strategic Finance at Solid Biosciences since April 2024, Charles has held key positions at Cartesian Therapeutics, Selecta Biosciences, EQRx, Dicerna Pharmaceuticals, Foundation Medicine, Philips Healthcare, and Iron Mountain. Academic credentials include an M.B.A. from Boston College and a BA in Economics/Finance from the University of Massachusetts Amherst.